Since cAMP has the ability to abrogate p53 accumulation and apoptosis in acute lymphoblastic leukemia cells (31), understanding the mechanism mediating this inhibitory effect is of great importance for effective therapeutic strategies in ALL. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.